148 related articles for article (PubMed ID: 37959278)
1. Corticophobia among Parents of Children with Atopic Dermatitis: Assessing Major and Minor Risk Factors for High TOPICOP Scores.
Herzum A; Occella C; Gariazzo L; Pastorino C; Viglizzo G
J Clin Med; 2023 Oct; 12(21):. PubMed ID: 37959278
[TBL] [Abstract][Full Text] [Related]
2. Corticosteroid phobia (corticophobia) in parents of young children with atopic dermatitis and their health care providers.
Bos B; Antonescu I; Osinga H; Veenje S; de Jong K; de Vries TW
Pediatr Dermatol; 2019 Jan; 36(1):100-104. PubMed ID: 30338542
[TBL] [Abstract][Full Text] [Related]
3. TOPICOP©: a new scale evaluating topical corticosteroid phobia among atopic dermatitis outpatients and their parents.
Moret L; Anthoine E; Aubert-Wastiaux H; Le Rhun A; Leux C; Mazereeuw-Hautier J; Stalder JF; Barbarot S
PLoS One; 2013; 8(10):e76493. PubMed ID: 24146878
[TBL] [Abstract][Full Text] [Related]
4. A low level of health literacy is a predictor of corticophobia in atopic dermatitis.
Gomes TF; Kieselova K; Guiote V; Henrique M; Santiago F
An Bras Dermatol; 2022; 97(6):704-709. PubMed ID: 36057460
[TBL] [Abstract][Full Text] [Related]
5. Healthcare utilization in Danish children with atopic dermatitis and parental topical corticosteroid phobia.
Gerner T; Haugaard JH; Vestergaard C; Deleuran M; Jemec GB; Mortz CG; Agner T; Egeberg A; Skov L; Thyssen JP
Pediatr Allergy Immunol; 2021 Feb; 32(2):331-341. PubMed ID: 33047404
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Atopic Dermatitis and Corticophobia on the Quality of Family Life.
Kotarski O; Pečnjak M; Blekić M; Bukvić I; Kljaić Bukvić B
Acta Dermatovenerol Croat; 2023 Aug; 31(1):3-10. PubMed ID: 37843083
[TBL] [Abstract][Full Text] [Related]
7. Topical Corticosteroid Concerns Among Parents of Children with Psoriasis versus Atopic Dermatitis: A French Multicenter Cross-Sectional Study.
Moawad S; Mahé E; Aubert-Wastiaux H; Phan A; Maruani A; Chiaverini C; Bodemer C; Mazereeuw-Hautier J; Lasek-Duriez A; Droitcourt C; Barbarot S; Beauchet A; Bursztejn AC;
Am J Clin Dermatol; 2018 Apr; 19(2):261-265. PubMed ID: 28849428
[TBL] [Abstract][Full Text] [Related]
8. Topical corticosteroid phobia among caretakers of children with atopic dermatitis: A cross-sectional study using TOPICOP in Japan.
Saito-Abe M; Futamura M; Yamamoto-Hanada K; Yang L; Suzuki K; Ohya Y
Pediatr Dermatol; 2019 May; 36(3):311-316. PubMed ID: 30882946
[TBL] [Abstract][Full Text] [Related]
9. Topical Corticosteroid Phobia Among Healthcare Professionals Using the TOPICOP Score.
Lambrechts L; Gilissen L; Morren MA
Acta Derm Venereol; 2019 Oct; 99(11):1004-1008. PubMed ID: 31099401
[TBL] [Abstract][Full Text] [Related]
10. Linguistic Validation and Reliability of the Croatian Version of the TOPICOP Questionnaire.
Markota Čagalj A; Markic J; Vuković D; Šitum Čeprnja Z; Gogić Salapić T; Buljan I; Pranić SM
Medicina (Kaunas); 2024 Jun; 60(6):. PubMed ID: 38929585
[No Abstract] [Full Text] [Related]
11. Corticosteroid fear in parents of children with atopic dermatitis.
Brunner C; Theiler M; Znoj H; Schwieger-Briel A; Luchsinger I; Weibel L; Seliner B
Pflege; 2024 Jan; ():. PubMed ID: 38294181
[No Abstract] [Full Text] [Related]
12. Evaluation of corticophobia in patients with atopic dermatitis and psoriasis using the TOPICOP© score.
Starbek Zorko M; Benko M; Rakuša M; Prunk Zdravković T
Acta Dermatovenerol Alp Pannonica Adriat; 2023 Dec; 32(4):135-139. PubMed ID: 38126095
[TBL] [Abstract][Full Text] [Related]
13. Reducing corticosteroid phobia in pharmacy staff and parents of children with atopic dermatitis.
Koster ES; Philbert D; Zheng X; Moradi N; de Vries TW; Bouvy ML
Int J Clin Pharm; 2021 Oct; 43(5):1237-1244. PubMed ID: 33582952
[TBL] [Abstract][Full Text] [Related]
14. Topical corticosteroid phobia in atopic dermatitis: International feasibility study of the TOPICOP score.
Stalder JF; Aubert H; Anthoine E; Futamura M; Marcoux D; Morren MA; Trzeciak M; Szalai Z; Veres K; Deleuran M; Vestergaard C; Boralevi F; Chu CY; De Raeve L; Svensson Å; Fölster-Holst R; Buchner M; Takaoka R; Aoki V; Chernyshov P; Chernyshova L; Murrell DF; Zhao C; Mckinster CD; Von Kobyletzky L; Eichenfield L; Totri C; Lio P; Seneschal J; Moret L; Barbarot S
Allergy; 2017 Nov; 72(11):1713-1719. PubMed ID: 28439896
[TBL] [Abstract][Full Text] [Related]
15. Topical Corticosteroid Phobia Among Parents of Children with Atopic Dermatitis (Eczema)- A Cross-Sectional Study.
Albogami MF; AlJomaie MS; Almarri SS; Al-Malki S; Tamur S; Aljaid M; Khayat A; Alzahrani A
Patient Prefer Adherence; 2023; 17():2761-2772. PubMed ID: 37936715
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial.
Simpson EL; Silverberg JI; Thyssen JP; Viguier M; Thaçi D; de Bruin-Weller M; Weidinger S; Chan G; DiBonaventura M; Biswas P; Feeney C; Koulias C; Cork MJ
Am J Clin Dermatol; 2023 Jul; 24(4):609-621. PubMed ID: 37213005
[TBL] [Abstract][Full Text] [Related]
17. Topical corticosteroid phobia in parents of pediatric patients with atopic dermatitis: a multicentre survey.
El Hachem M; Gesualdo F; Ricci G; Diociaiuti A; Giraldi L; Ametrano O; Occella C; Fortina AB; Milioto M; Arcangeli F; Simonetti O; Giancristoforo S; Calamelli E; Mazzatenta C; Neri I
Ital J Pediatr; 2017 Feb; 43(1):22. PubMed ID: 28245844
[TBL] [Abstract][Full Text] [Related]
18. Long term effects of digital education among healthcare professionals in paediatric dermatology: Opportunities for improving care.
Ragamin A; Schappin R; Witkam WCAM; Spiering M; Mendels E; Schuttelaar MLA; Pasmans SGMA
Skin Health Dis; 2022 Sep; 2(3):e143. PubMed ID: 36092257
[TBL] [Abstract][Full Text] [Related]
19. Topical tacrolimus for atopic dermatitis.
Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Reich K; Teixeira HD; de Bruin-Weller M; Bieber T; Soong W; Kabashima K; Werfel T; Zeng J; Huang X; Hu X; Hendrickson BA; Ladizinski B; Chu AD; Silverberg JI
Lancet; 2021 Jun; 397(10290):2169-2181. PubMed ID: 34023009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
